Skip to main content
MorphoSys AG logo

MorphoSys AG — Investor Relations & Filings

Ticker · MOR ISIN · DE000A3H2XW6 LEI · 529900493806K77LRE72 F Manufacturing
Open in API
Filings indexed 1,418 across all filing types
Latest filing 2007-10-25 Interim / Quarterly Rep…
Country DE Germany
Listing F MOR

About MorphoSys AG

https://www.morphosys.com/

MorphoSys AG is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines, primarily for cancer patients. The company specializes in creating therapeutic monoclonal antibodies, utilizing its long-standing expertise and proprietary technology platforms to generate fully human antibodies. Its research and development efforts are concentrated on building a pipeline of novel treatments to address significant unmet medical needs in oncology. In February 2024, Novartis entered into an agreement to acquire MorphoSys, aiming to integrate its antibody technologies and oncology pipeline.

Recent filings

Filing Released Lang Actions
Q3 Bericht 2007
Interim / Quarterly Report Classification · 100% confidence The document is a 'Zwischenbericht' (Interim Report) for the period January to September 2007 for MorphoSys AG. It contains comprehensive financial statements, including the income statement, balance sheet, cash flow statement, and management discussion and analysis (Konzern-Zwischenlagebericht). It is not an announcement of a report, but the report itself, containing substantive financial data. 9M 2007
2007-10-25 German
Q3 Report 2007
Interim / Quarterly Report Classification · 100% confidence The document is titled '3rd Interim Report January – September 2007' and contains comprehensive financial statements, including consolidated statements of operations, balance sheets, cash flows, and notes to the interim consolidated financial statements. It provides a detailed management report and financial analysis for the nine-month period. It is not an announcement or a certification, but the full interim report itself, fitting the definition of an Interim / Quarterly Report (IR). 9M 2007
2007-10-25 English
German Healthcare Conference
Interim / Quarterly Report Classification · 100% confidence The document contains detailed financial tables, including a Profit & Loss Statement for H1 2007 and a Balance Sheet comparing 06/30/2007 to 12/31/2006. It provides substantive financial data and analysis for a period shorter than a full fiscal year (H1), which fits the definition of an Interim/Quarterly Report (IR). H1 2007
2007-10-02 English
2nd Sal. Oppenheim European Healthcare Conference
Investor Presentation Classification · 98% confidence The document is titled '2nd Sal. Oppenheim European Healthcare Conference' and contains slides detailing company information ('MorphoSys at a Glance'), business strategy, pipeline updates (MOR 103, MOR202), financial performance tables (Revenue, P&L, Balance Sheets for H1 2007), and future goals for 2007. This structure, including forward-looking statements and detailed financial summaries presented in a slide format for an external conference, strongly indicates an Investor Presentation (IP). It is not a formal regulatory filing like a 10-K or an Earnings Release (ER), which typically contains less visual/presentation structure and more mandated disclosure text. It is also not a Call Transcript (CT).
2007-09-04 English
Q2 Bericht 2007
Interim / Quarterly Report Classification · 100% confidence The document is a 'Zwischenbericht' (Interim Report) for the period January to June 2007 for MorphoSys AG. It contains comprehensive financial statements (IFRS), including the income statement, balance sheet, cash flow statement, and management discussion and analysis (Konzern-Zwischenlagebericht). It is not an announcement of a report, but the report itself, containing substantive financial data. H1 2007
2007-07-30 German
Q2 Report 2007
Interim / Quarterly Report Classification · 100% confidence The document is titled '2nd Interim Report January – June 2007' and contains comprehensive financial statements (Consolidated Statements of Operations, Balance Sheets, Cash Flows) and detailed management analysis for the six-month period. It is not an announcement of a report, but the report itself, fitting the definition of an Interim/Quarterly Report. H1 2007
2007-07-30 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.